Genzyme Corp. has agreed to pay a $22.3 million settlement in a lawsuit in which two former sales representatives alleged that the company said a product called Seprafilm could be used in a type of surgery for which it was not approved.
The whistle-blower lawsuit was filed in Florida under the federal False Claims Act, which allows private citizens to file suit on behalf of the government and then share in any financial settlement, according to an article earlier this week in the Tampa Bay Times. Court documents allege that salesman encouraged doctors to use the product in a type of surgery for which it was not approved. Those doctors would then seek improper reimbursement claims.
